Beta 3 Adrenoreceptor Agonist for the Management of Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia: A Systematic Review
Tae Wook Kang, Su Jin Kim, Myung Ha Kim, Jae Hung Jung
Int Neurourol J. 2021;25(3):182-191. Published online 2021 Sep 30 DOI: https://doi.org/10.5213/inj.2142068.034
Citations to this article as recorded by 
Inside the Biology of the β3-Adrenoceptor
Amada Pasha, Annalisa Tondo, Claudio Favre, Maura Calvani
Biomolecules.2024; 14(2): 159. CrossRef
Novel pharmacotherapeutic avenues for bladder storage dysfunction in men
Kang Jun Cho, Joon Chul Kim
Expert Opinion on Pharmacotherapy.2024; : 1. CrossRef
Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron 50 mg in Sexually Active Men With Bothersome Overactive Bladder Symptoms – A Multicenter, Randomized Study
Chih-Chieh Lin, Hann-Chorng Kuo, Jian-Ri Li, Yao-Chi Chuang
International Neurourology Journal.2023; 27(3): 182. CrossRef
Risks and side effects in the medical management of benign prostatic hyperplasia
Abdulghafour Halawani, Ryan Paterson, Tianshuang Zhong, Katie Du, Runhan Ren, Connor M. Forbes
Prostate International.2023;[Epub] CrossRef
Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
Collyn O'Quin, Kathryn L White, John R Campbell, Sarah H Myers, Shilpadevi Patil, Debbie Chandler, Shahab Ahmadzadeh, Giustino Varrassi, Sahar Shekoohi, Alan D Kaye
Cureus.2023;[Epub] CrossRef
Lower Urinary Tract Symptoms With a View Beyond the Bladder and Prostate
Su Jin Kim
International Neurourology Journal.2022; 26(2): 85. CrossRef